Use of artificial intelligence chatbots as a source of multiple sclerosis information: a survey of people with multiple sclerosis and healthcare professionals

Background Artificial intelligence (AI) chatbots are increasingly used to access health information, but their use for multiple sclerosis (MS)-related information among people with MS (pwMS) and healthcare professionals (HCPs) remains insufficiently characterised. This study aimed to characterise their use, factors associated with AI chatbot use, and self-reported information verification in these groups. Methods This multicentre cross-sectional study included adult pwMS and HCPs involved in their care. Data were collected using a purpose-designed survey. Results Overall, 757 pwMS (median age 45 years; 69.9% women) and 122 HCPs (median age 44.5 years; 80.3% women) participated. AI chatbots were used by 26.3% of pwMS and 39.3% of HCPs. Among pwMS, use was associated with younger age (OR = 0.96, p < 0.001) and shorter disease duration ( p = 0.002). Among HCPs, age showed opposite sex-specific associations: use decreased with age in women (OR = 0.95, p = 0.017) but non-significantly increased with age in men (OR = 1.04, p = 0.263). More than 5 years of MS-care experience was associated with non-significantly lower odds of use (OR = 0.43, p = 0.054). ChatGPT was the most frequently used chatbot among pwMS and HCPs (82.9% and 91.7%, respectively), followed by Google Gemini (34.2% and 39.6%). Rapid responses and continuous availability were the principal reasons for use. HCPs reported verifying chatbot-generated information more often than pwMS. Among pwMS, verification was associated with younger age, higher education, residence in a larger urban area, and shorter disease duration. Conclusion AI chatbots are commonly used for MS-related information by both pwMS and HCPs. Targeted education can promote critical appraisal, appropriate verification, and awareness of the limitations and risks of AI-generated health information.

Authors

Institutions

Publication Details

Journal
Frontiers in Neurology
Published
2026-11-18
DOI
https://doi.org/10.3389/fneur.2026.1976979
Primary Topic
Artificial Intelligence in Healthcare and Education
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Use of artificial intelligence chatbots as a source of multiple sclerosis information: a survey of people with multiple sclerosis and healthcare professionals

Pavel Hradílek, Dana Horáková, Petra Ovesná, Marta Vachová et al.
5 links
Frontiers in Neurology
Artificial Intelligence in Healthcare and Education
article

Use of artificial intelligence chatbots as a source of multiple sclerosis information: a survey of people with multiple sclerosis and healthcare professionals

Pavel Hradílek, Dana Horáková, Petra Ovesná, Marta Vachová, Blanka Adamová, Matouš Rous, Iva Šrotová, Sabina Vejrychová, Eva Kubala Havrdová, Adam Mičánek
article en

Abstract

Background Artificial intelligence (AI) chatbots are increasingly used to access health information, but their use for multiple sclerosis (MS)-related information among people with MS (pwMS) and healthcare professionals (HCPs) remains insufficiently characterised. This study aimed to characterise their use, factors associated with AI chatbot use, and self-reported information verification in these groups. Methods This multicentre cross-sectional study included adult pwMS and HCPs involved in their care. Data were collected using a purpose-designed survey. Results Overall, 757 pwMS (median age 45 years; 69.9% women) and 122 HCPs (median age 44.5 years; 80.3% women) participated. AI chatbots were used by 26.3% of pwMS and 39.3% of HCPs. Among pwMS, use was associated with younger age (OR = 0.96, p < 0.001) and shorter disease duration ( p = 0.002). Among HCPs, age showed opposite sex-specific associations: use decreased with age in women (OR = 0.95, p = 0.017) but non-significantly increased with age in men (OR = 1.04, p = 0.263). More than 5 years of MS-care experience was associated with non-significantly lower odds of use (OR = 0.43, p = 0.054). ChatGPT was the most frequently used chatbot among pwMS and HCPs (82.9% and 91.7%, respectively), followed by Google Gemini (34.2% and 39.6%). Rapid responses and continuous availability were the principal reasons for use. HCPs reported verifying chatbot-generated information more often than pwMS. Among pwMS, verification was associated with younger age, higher education, residence in a larger urban area, and shorter disease duration. Conclusion AI chatbots are commonly used for MS-related information by both pwMS and HCPs. Targeted education can promote critical appraisal, appropriate verification, and awareness of the limitations and risks of AI-generated health information.

Frontiers in NeurologyVol. 17
University of Ostrava (CZ), Charles University (CZ), Masaryk University (CZ), University Hospital Brno (CZ), University Hospital Olomouc (CZ), General University Hospital in Prague (CZ), Palacký University Olomouc (CZ)
Good health and well-being
Artificial Intelligence in Healthcare and Education
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon